Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T20:42:02.590Z.
Calculation as of: 2026-10-06T20:42:02.590Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e0aae41c25609cbe98cd8c59fbdc20e812e1ea61d6a67e0b8df2c56749153647
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2024-03-26.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
PS RATIO AVG TTM
N/A
PS RATIO AVG 3Y
N/A
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$369.50M
PS Ratio
15.52
TTM Avg
5.21
3Y Avg
4.17
5Y Avg
16.03
Market Cap
$359.53M
PS Ratio
6.07
TTM Avg
6.19
3Y Avg
8.23
5Y Avg
116.26
Market Cap
$355.43M
PS Ratio
N/A
TTM Avg
73.59
3Y Avg
73.59
5Y Avg
73.59
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | $374.50M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $376.01M | 1.63 | 1.64 | 1.82 | 17.54 |
| Zura Bio Limited (ZURA)vs › | $376.19M | N/A | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $369.50M | 15.52 | 5.21 | 4.17 | 16.03 |
| Orthofix Medical Inc. (OFIX)vs › | $380.37M | 0.46 | 0.60 | 0.69 | 0.86 |
| REGENXBIO Inc. (RGNX)vs › | $385.15M | 2.21 | 3.86 | 5.22 | 5.56 |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | 36.69 | 117.36 | 59.63 | 59.63 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | 6.07 | 6.19 | 8.23 | 116.26 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | N/A | 73.59 | 73.59 | 73.59 |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 1.18 | 1.31 | 1.47 | 1.73 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-26 |
| Q1 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q2 FY2026Period ended 2026-06-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-11 |
| TTM revenue | $0 |
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2024-03-26 | 3800.87 |
| 2024-03-25 | 3553.19 |
| 2024-03-22 | 3932.35 |
| 2024-03-21 | 4112.77 |
| 2024-03-20 | 3982.81 |
| 2024-03-19 | 4051.61 |
| 2024-03-18 | 4089.83 |
| 2024-03-15 | 4542.39 |
| 2024-03-14 | 4516.40 |
| 2024-03-13 | 4598.96 |
| 2024-03-12 | 4433.84 |
| 2024-03-11 | 4508.75 |
| 2024-03-08 | 4383.38 |
| 2024-03-07 | 4400.20 |
| 2024-03-06 | 4320.70 |
| 2024-03-05 | 4296.24 |
| 2024-03-04 | 4235.08 |
| 2024-03-01 | 4242.72 |
| 2024-02-29 | 4154.05 |
| 2024-02-28 | 4291.65 |
| 2024-02-27 | 4206.03 |
| 2024-02-26 | 4287.06 |
| 2024-02-23 | 4262.60 |
| 2024-02-22 | 4152.52 |
| 2024-02-21 | 4212.15 |
| 2024-02-20 | 4313.05 |
| 2024-02-16 | 4510.28 |
| 2024-02-15 | 4548.51 |
| 2024-02-14 | 4569.91 |
| 2024-02-13 | 4542.39 |
| 2024-02-12 | 4576.03 |
| 2024-02-09 | 4602.02 |
| 2024-02-08 | 4586.73 |
